Rhetorical gamesmanship in the nano debates over sunscreens and nanoparticles

被引:30
作者
Berube, David M. [1 ]
机构
[1] N Carolina State Univ, Dept Commun, Publ Commun Sci & Technol PCOST Project, Raleigh, NC 27695 USA
基金
美国国家科学基金会;
关键词
Nanotechnology; Nanoparticles; Sunscreens; Titanium dioxide; Zinc oxide; Background; Literature review; Literature survey; Environmental health and safety (EHS); Risk communication; Risk profile shifts; Governance; Societal implications;
D O I
10.1007/s11051-008-9362-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Communication of risk profiles associated with sunscreens incorporating nanoparticles has been challenging when some communicators shift risk profiles from highly problematic nanoparticles to others, which are much less problematic. This article vets a popular publication from a civic advocacy group that cited scientific research papers to make environmental health and safety claims. The phenomenon of risk profile shifts is demonstrated by re-examining the scientific articles being cited. In addition, the authors for correspondence for each of the articles cited were interviewed via email and their comments about the claims made are included.
引用
收藏
页码:23 / 37
页数:15
相关论文
共 63 条
[1]  
[Anonymous], 2007, CODEX ALIMENTARIUS F
[2]  
[Anonymous], NAN SUNSCR CONS GUID
[3]   Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children [J].
Autier, P ;
Doré, JF ;
Cattaruzza, MS ;
Renard, F ;
Luther, H ;
Gentiloni-Silverj, F ;
Zantedeschi, E ;
Mezzetti, M ;
Monjaud, I ;
Andry, M ;
Osborn, JF ;
Grivegnée, AR .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (24) :1873-1880
[4]   SOIL PARTICLES IN THE TISSUES OF THE FOOT IN ENDEMIC ELEPHANTIASIS OF THE LOWER LEGS [J].
BLUNDELL, G ;
HENDERSON, WJ ;
PRICE, EW .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1989, 83 (04) :381-385
[5]   Toxicological hazards of inhaled nanoparticles - Potential implications for drug delivery [J].
Borm, PJA ;
Kreyling, W .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2004, 4 (05) :521-531
[6]  
BUTZ T, 2005, NO EVIDENCE NANOPART
[7]  
CEDARBLOOM J, 1986, CRITICAL REASONING U
[8]  
*CONS REP, 2007, 727 CONS REP
[9]  
CORACHAN M, 1988, TROP GEOGR MED, V40, P359
[10]  
DELRIEU P, 2006, FDA PUBL M NAN BETH